Brief: Polypeptide Group AG And Cytovance Biologics Announce Collaboration For Microbial And Mammalian-Expressed Peptide Drugs
Jan 13 (Reuters) - PolyPeptide Group AG PPGN.S :
* POLYPEPTIDE GROUP AG AND CYTOVANCE BIOLOGICS ANNOUNCE
COLLABORATION FOR MICROBIAL AND MAMMALIAN-EXPRESSED PEPTIDE
DRUGS
Source text: ID:nBw7qx5rwa
Further company coverage: PPGN.S
(Gdansk Newsroom)
(((( gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));))
Recent news on PolyPeptide AG
See all newsBrief: Polypeptide Group Definitive Interim Result Of The Public Tender Offer Of Samsung Biologics
Brief: Polypeptide Group Provisional Interim Result Of The Public Tender Offer Of Samsung Biologics Co
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Samsung Biologics to launch takeover bid for PolyPeptide in September (updated)